Home > News > Cancer study gets tiny
October 30th, 2007
Cancer study gets tiny
Abstract:
Joe DeSimone, who has a joint professorship at UNC-CH and N.C. State University, said he hopes his technology to deliver drugs to specific cells will begin clinical trials in about 14 months.
UNC-CH materials science professor Otto Zhou, whose work involves carbon nanotubes, thinks that a company he co-founded will produce new imaging devices for humans in less than two years. He says it has the potential to replace conventional X-rays.
The products of Zhou, DeSimone and other scientists are closer to market in part because of an alliance begun three years ago by the National Cancer Institute. Looking for a way to capitalize on nanotechnology's potential in cancer research, the institute brought together university scientists and private companies from across the country.
Source:
newsobserver.com
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||